Alpha 2.0
Login Register
» Authors » Janneke Verloop

Janneke Verloop

Explore the profile of Janneke Verloop including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 271
Followers 0
Related Specialties
Oncology
General Medicine
Radiology
Top 10 Co-Authors
Sabine Siesling
Thijs van Dalen
Joke C Korevaar
Marianne J Heins
Jelle Wesseling
Kelly M de Ligt
Linda de Munck
A Elise van Leeuwen
Paula H M Elkhuizen
Vivianne C G Tjan-Heijnen
Published In
Ned Tijdschr Geneeskd
Lancet
J Surg Oncol
J Hematol Oncol
BMC Med Res Methodol
Affiliations
Soon will be listed here.
Recent Articles
1.
Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT Study
Ragusi M, H M van der Velden B, Meeuwis C, Tetteroo E, Coerkamp E, van Nijnatten T, et al.
Radiology . 2023 Mar; 307(4):e221922. PMID: 36975820
Background Several single-center studies found that high contralateral parenchymal enhancement (CPE) at breast MRI was associated with improved long-term survival in patients with estrogen receptor (ER)-positive and human epidermal growth...
2.
De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study
de Wild S, de Munck L, Simons J, Verloop J, van Dalen T, Elkhuizen P, et al.
Lancet Oncol . 2022 Aug; 23(9):1201-1210. PMID: 35952707
Background: Primary chemotherapy in breast cancer poses a dilemma with regard to adjuvant locoregional radiotherapy, as guidelines for locoregional radiotherapy were originally based on pathology results of primary surgery. We...
3.
Varying severities of symptoms underline the relevance of personalized follow-up care in breast cancer survivors: latent class cluster analyses in a cross-sectional cohort
de Ligt K, de Rooij B, Walraven I, Heins M, Verloop J, Siesling S, et al.
Support Care Cancer . 2022 Jun; 30(10):7873-7883. PMID: 35727375
Purpose: Insights into the severity of co-existing symptoms can help in identifying breast cancer survivors in need of symptom management. We aimed to identify subgroups of breast cancer survivors based...
4.
Opportunities and obstacles in linking large health care registries: the primary secondary cancer care registry - breast cancer
Heins M, de Ligt K, Verloop J, Siesling S, Korevaar J
BMC Med Res Methodol . 2022 Apr; 22(1):124. PMID: 35477392
Background: The growing volume of health data provides new opportunities for medical research. By using existing registries, large populations can be studied over a long period of time. Patient-level linkage...
5.
Adverse health effects after breast cancer up to 14 years after diagnosis
Heins M, de Ligt K, Verloop J, Siesling S, Korevaar J
Breast . 2021 Dec; 61:22-28. PMID: 34891036
Background: The number of breast cancer survivors increases, but information about long-term adverse health effects in breast cancer survivors is sparse. We aimed to get an overview of the health...
6.
Identification of Risk of Cardiovascular Disease by Automatic Quantification of Coronary Artery Calcifications on Radiotherapy Planning CT Scans in Patients With Breast Cancer
Gal R, van Velzen S, Hooning M, Emaus M, van der Leij F, Gregorowitsch M, et al.
JAMA Oncol . 2021 May; 7(7):1024-1032. PMID: 33956083
Importance: Cardiovascular disease (CVD) is common in patients treated for breast cancer, especially in patients treated with systemic treatment and radiotherapy and in those with preexisting CVD risk factors. Coronary...
7.
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study
Eijkelboom A, de Munck L, Vrancken Peeters M, Broeders M, Strobbe L, Bos M, et al.
J Hematol Oncol . 2021 Apr; 14(1):64. PMID: 33865430
Background: The onset of the COVID-19 pandemic forced the Dutch national screening program to a halt and increased the burden on health care services, necessitating the introduction of specific breast...
8.
Impact on Quality of Documentation and Workload of the Introduction of a National Information Standard for Tumor Board Reporting
Ebben K, Sieswerda M, Luiten E, Heijns J, van der Pol C, Bessems M, et al.
JCO Clin Cancer Inform . 2020 Apr; 4:346-356. PMID: 32324446
Purpose: Tumor boards, clinical practice guidelines, and cancer registries are intertwined cancer care quality instruments. Standardized structured reporting has been proposed as a solution to improve clinical documentation, while facilitating...
9.
Radiotherapy after primary CHEMotherapy (RAPCHEM): Practice variation in a Dutch registration study (BOOG 2010-03)
Boersma L, Verloop J, Voogd A, Elkhuizen P, Houben R, van Leeuwen A, et al.
Radiother Oncol . 2020 Feb; 145:201-208. PMID: 32058873
Background: We conducted a prospective cohort study in the Netherlands (RAPCHEM: NCT01279304, BOOG 2010-03) in breast cancer (BC) patients treated with primary systemic therapy (PST), followed by surgery and post-operative...
10.
Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit
van Bommel A, Spronk P, Vrancken Peeters M, Jager A, Lobbes M, Maduro J, et al.
J Surg Oncol . 2016 Nov; 115(3):243-249. PMID: 27885679
Background: In 2011, the NABON Breast Cancer Audit (NBCA) was instituted as a nation-wide audit to address quality of breast cancer care and guideline adherence in the Netherlands. The development...